Journal of Thyroid Cancer

Instructions For Author

Comprehensive guidance for preparing and submitting thyroid cancer manuscripts.

Clear GuidelinesFollow standards for rapid review.

Ethics FirstProtect patient privacy and consent.

Data TransparencyShare clinical and molecular data.

Open AccessGlobal visibility after publication.

Submit Manuscript Simple Submission

Journal at a Glance

ISSN: 2574-4496
DOI Prefix: 10.14302/issn.2574-4496
License: CC BY 4.0
Peer reviewed open access journal

Scope Alignment

Thyroid carcinoma, endocrine oncology, surgical and medical management, molecular diagnostics, and survivorship care. We prioritize evidence that improves diagnosis and outcomes.

Publishing Model

Open access, single blind peer review, and rapid publication after acceptance and production checks. Metadata validation and DOI registration are included.

Review Time18 daysFrom submission

Acceptance Rate56%Current average

Decision Time18 daysSubmission to decision

Publication5 daysAfter acceptance

Instructions for Authors

Journal of Thyroid Cancer publishes rigorous thyroid cancer research that advances diagnosis, treatment, and survivorship care.

Follow these guidelines to ensure a smooth editorial review and production process.

Manuscript Preparation

Use clear, concise language and define all abbreviations
Include structured abstracts with objectives, methods, results, and conclusions
Provide keywords that reflect thyroid cancer subtypes and methods
Ensure references are complete and include DOIs where available

Reporting Standards

STROBE for observational studies
CONSORT for randomized trials
PRISMA for systematic reviews
CARE for case reports
TREND for non randomized evaluations

Ethics and Data

Include ethics approvals and informed consent statements
Provide data availability statements and repository links
Describe diagnostic criteria and staging methods
Document patient privacy safeguards and deidentification

Submission Methods

ManuscriptZone

Submit via https://oap.manuscriptzone.net for full tracking and reviewer communication.

Simple Submission

Use the streamlined form at https://openaccesspub.org/manuscript-submission-form for rapid submission.

After Submission

Editorial Screening

Scope fit and compliance checks

Peer Review

Single blind review by experts

Revision

Address reviewer comments and resubmit

Production

Copyediting, proofs, and DOI registration

Manuscript Components

Title page with author affiliations and corresponding author details
Abstract and keywords
Introduction describing clinical context and research gap
Methods including diagnostic and treatment protocols
Results with tables, figures, and statistical analysis
Discussion highlighting implications for clinical care

Figures and Tables

Provide high resolution figures and editable tables. Ensure all units and abbreviations are defined. Figures should be cited in order and include descriptive captions.

Submission Checklist

Cover letter explaining novelty and clinical relevance
Conflict of interest and funding disclosures
Ethics approvals and consent documentation
Data availability statement
Figure and table files uploaded

Author FAQ

Do you accept preprints?

Yes. Disclose preprints in the cover letter.

Is language editing required?

No, but it is available upon request.

Can I submit supplementary data?

Yes. Provide it with clear labeling and descriptions.

JTC Commitment

JTC is committed to rigorous, transparent publishing in thyroid cancer research and care. We emphasize reproducible clinical methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in endocrine oncology, surgical outcomes, and translational thyroid research.

Ready to Submit Your Manuscript?

Use ManuscriptZone or the Simple Submission Form to begin.

Submit via ManuscriptZone Simple Submission Form

Public Access and Funder Compliance

Some authors are required by their funders to make their research publicly available. Under the 2024 NIH Public Access Policy, Author Accepted Manuscripts accepted for publication on or after July 1, 2025, must be submitted to PubMed Central upon acceptance and made publicly available without embargo on the official date of publication.

What JTC provides: JTC publishes the Version of Record under the Creative Commons Attribution 4.0 International licence. The journal also permits authors to deposit their Author Accepted Manuscript in funder-designated repositories. Upon acceptance, we confirm the accepted manuscript version and record the funder and grant information supplied by the authors.

Author responsibility: JTC does not currently deposit manuscripts in PubMed Central on behalf of authors. Authors are responsible for determining which funder requirements apply, initiating the appropriate repository submission and completing any required NIHMS approval steps.

Eligibility and successful processing through PubMed Central or NIHMS are determined according to the relevant funder and NIH/NLM requirements.

Important: The deposit of an individual article in PubMed Central may result in that article appearing in PubMed. It does not mean that JTC is indexed in MEDLINE, included in the PMC Journal List or that all JTC articles are available through PubMed. The journal's current coverage is listed on the Indexing page.

Journal of Thyroid Cancer – Instructions For Author